Glaucoma Treatment

What Is Glaucoma?

A chronic progressive eye condition, glaucoma involves structural and functional damage to the optic nerve, frequently associated with increased pressure within the eye. The optic nerve serves as the pathway for visual signals traveling from the eye to the brain; when this nerve sustains injury and remains untreated, irreversible vision loss may occur.

Recognized as a significant cause of preventable vision loss on a global scale, glaucoma can be managed effectively through timely detection and consistent therapeutic intervention to maintain visual function.

What Are the Types of Glaucoma?

Open-Angle Glaucoma

The most prevalent variant involves gradual deterioration of the eye’s fluid outflow mechanism, resulting in a slow increase in intraocular pressure. Vision typically declines imperceptibly as peripheral areas of the visual field are affected, with the patient often remaining unaware of changes during the early course.

Angle-Closure Glaucoma

This form develops when the eye’s drainage angle becomes narrowed or obstructed, which may occur acutely or gradually over time. The acute presentation may include sudden ocular discomfort, visual blurring, light halos, accompanying nausea, and headache, necessitating immediate medical attention.

Normal-Tension Glaucoma

Optic nerve deterioration consistent with glaucoma can manifest despite intraocular pressure remaining within typical ranges. This variant demands careful diagnostic assessment and attentive long-term surveillance.

What Are the Symptoms of Glaucoma?

• Open-angle presentations frequently remain asymptomatic throughout extended periods
• Incremental constriction of the peripheral visual field
• Progressive “tunnel vision” appearance in later disease stages
• Acute angle-closure presentations: acute eye discomfort, conjunctival injection, visual obscurity, luminous halos, associated gastrointestinal symptoms

Glaucoma carries the designation of a “silent thief of sight” due to its capacity to advance without apparent manifestation until vision deterioration becomes evident.

How Is Glaucoma Diagnosed?

Assessment and ongoing monitoring incorporate:

• Tonometry: quantifying intraocular pressure values
• Optic nerve evaluation: examining the anatomy of the optic disc
• Visual field assessment (perimetry): documenting any peripheral vision compromise
• Optical coherence tomography (OCT): measuring retinal nerve fibre layer dimensions
• Gonioscopy: evaluating the structural anatomy of the drainage angle

How Is Glaucoma Treated?

Eye Drops

Topical pharmaceutical agents designed to reduce intraocular pressure typically constitute the initial therapeutic approach. Adherence to the prescribed instillation regimen directly influences treatment outcomes.

Laser Treatment

Procedures including selective laser trabeculoplasty function to enhance aqueous outflow and diminish intraocular pressure. Laser-based iridotomy represents an intervention option in acute angle-closure presentations.

Surgical Methods

Should pharmacological and laser modalities prove insufficient in achieving adequate pressure control, procedures such as trabeculectomy, aqueous shunt device placement, or minimally invasive glaucoma surgery (MIGS) may be evaluated for consideration.

The Importance of Follow-Up in Glaucoma Treatment

Glaucoma management extends throughout the patient’s lifetime rather than concluding with initial intervention. Intraocular pressure levels and optic nerve status may shift considerably with time; therefore, periodic clinical evaluation remains essential for determining treatment efficacy and making adjustments to the management strategy as indicated.

• Consistent and correct administration of prescribed medications
• Adherence to scheduled clinical appointments
• Periodic assessment through visual field testing and OCT imaging
• Prompt medical consultation for acute eye discomfort or abrupt visual changes

Can Vision Lost to Glaucoma Be Recovered?

The structural damage sustained by the optic nerve in glaucoma represents a permanent alteration that cannot be reversed through available therapies. Consequently, the therapeutic objective centers on preservation of remaining vision and prevention or deceleration of further deterioration. The achievement of these aims is substantially influenced by the timing of initial diagnosis and the consistency of ongoing treatment.